Login / Signup

A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.

Benjamin SpeichFrédérique ChammartinDaniel SmithMarcel P StoecklePatrizia AmicoAnna L EichenbergerBarbara HasseMacé M SchuurmansThomas MüllerMichael TammMichael DickenmannIrene A AbelaAlexandra TrkolaHans H HirschOriol ManuelMatthias CavassiniLars G HemkensMatthias BrielNicolas J MuellerAndri RauchHuldrych F GünthardMichael T KollerHeiner C BucherKatharina Kusejkonull null
Published in: Trials (2021)
ClinicalTrials.gov NCT04805125 . Registered on March 18, 2021.
Keyphrases